{"title":"Lithium salts as a possible therapeutic option for SARS CoV 2 infection","authors":"O. Soriano-Torres","doi":"10.53069/wiji/0000001","DOIUrl":"https://doi.org/10.53069/wiji/0000001","url":null,"abstract":"SARS-CoV-2 causes a severe respiratory disease (COVID-19) characterized by marked deregulation of the immune system, which provokes a hyper-inflammatory state. With the uncertainties regarding the efficacy of vaccines against new variants, there is an urgent need for repurposing current drugs, which have a mechanism of action that justifies their use for the treatment of COVID-19. To summarize the current evidence on the mechanisms of action of lithium salts on viral infections and the immune system. Google Scholar and PubMed were used to the key words “lithium,” “immune system,” “inflammation,” “antiviral,” “SARS-CoV- 2,” and “coronavirus.” We identified 78 papers: 52 were original works (clinical trials, descriptive studies or preclinical assessments), 23 were systematic reviews of related topics, two government reports and one book. Lithium has shown direct antiviral effects by inhibiting the in vitro replication of several types of viruses. It may also have indirect antiviral effects by enhancing the antiviral response which is mediated by inhibition of the expression of programmed cell-death protein 1 in cells from innate and acquired immunity. Moreover, lithium reduces inflammation by interfering with the production of pro-inflammatory cytokines. A small study in patients with COVID-19 was conducted in Spain with remarkable outcomes, but no preclinical specific evaluation was found. Lithium is a promising candidate for the treatment of COVID-19. Its use could have great relevance in the treatment of patients with severe cytokine storm. Preclinical and clinical trials are needed to assess the therapeutic capacity of lithium salts in the treatment of COVID-19 patients.","PeriodicalId":231101,"journal":{"name":"West Indian Journal of Immunology","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122674060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The breastmilk as guardian of an immune treasure","authors":"Leidiani Rodríguez-Pérez","doi":"10.53069/wiji/0000004","DOIUrl":"https://doi.org/10.53069/wiji/0000004","url":null,"abstract":"Breast milk is the most complete food for feeding neonates. In addition to its nutritional richness, it has multiple immune components that will participate both in the passive and active responses of the newborn and in the proper development and maturation of the immune system. Milk banks are institutions for collection, processing, and distribution of breast milk voluntarily donated to be used in cases where newborns cannot be fed by their own mother, at least during hospitalization period. This review aims to highlight the benefits of breast milk on the nutrition and maturation and functioning of the infant's immune system and therefore highlight the role of milk banks. The pasteurization process produces a decrease in the milk immune components, which is why these are kept in lower concentrations and still fulfill their functions in the newborn's immune system. The effect of this process on the cells of breast milk in newborns are not yet known.","PeriodicalId":231101,"journal":{"name":"West Indian Journal of Immunology","volume":"66 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126659754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Herbs and dietary supplements in rheumatoid arthritis: The clinical evidence","authors":"Y. Clement","doi":"10.53069/wiji/0000002","DOIUrl":"https://doi.org/10.53069/wiji/0000002","url":null,"abstract":"Rheumatoid arthritis (RA) is an autoimmune disease that results in the destruction of joint cartilage and bone with an accompanying cluster of inflammatory symptoms leading to the progressive deformity of multiple joints. Several disease modifying anti- rheumatic drugs (DMARDs) are available for the treatment of RA (which arrest or slow disease progression); however, these are sometimes associated with severe side effects. The market is inundated with herbal preparations and dietary supplements are as beneficial to relieve symptoms in RA either as alternatives to or for use alongside conventional medicines. This mini-review sought to determine whether these therapies are safe and efficacious for the treatment of RA. The strongest clinical evidence exists for short-term complementary use of Tripterygium wilfordii Hook F “thunder god vine”, γ-linolenic acid and fish oils for symptomatic relief. However, no long-term studies support the use of these supplements to either arrest or delay disease progression. Only a few studies are available for saffron, cinnamon, ginger andpomegranate which are insufficient to establish safety and efficacy. Other studies have shown that integrating traditional Chinese medicine with western medicine may be beneficial; however, most of these studies were poorly designed. A few studies have shown that folic acid and folinic acid supplementation may reduce the incidence of methotrexate-induced side effects and prevent discontinuation. Conclusion There is limited and biased evidence regarding the efficacy of probiotics.","PeriodicalId":231101,"journal":{"name":"West Indian Journal of Immunology","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116296153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Anti-polysaccharide IgA seen to be more polyreactive than IgG antibodies","authors":"Laura M. Reyes Díaz","doi":"10.53069/wiji/0000003","DOIUrl":"https://doi.org/10.53069/wiji/0000003","url":null,"abstract":"Polyreactive antibodies are natural antibodies. They bind with a low affinity to a variety of structurally unrelated antigens. IgA is the main antibody isotype that protects mucosal surfaces and can be produced against thymus-independent (polysaccharide) or thymus-dependent antigens (proteins). Nevertheless, the mucosal IgA polyreactive responses to polysaccharides are unknown. Neisseria meningitidis and Salmonella Typhi Ps were selected as the mucosal microorganisms. To explore the predominance of IgA over IgG isotypes in polyreactivity, a hybridoma system induced by polysaccharides was used. Mice were immunized with a standard protocol to produce monoclonal anti-Ps C from N. meningitidis and the Vi of S. Typhi antibodies. We used non-specific hybridoma supernatants to detect IgG and IgA anti A, C, Y, X, and Vi polyreactivity by indirect ELISA. Only one monoclonal antibody of nine secreting hybridomas in each system was obtained. Polyreactive responses against polysaccharides A, C, Y, and X of N. meningitidis and Vi of S. Typhi were obtained mainly from the IgA isotype. Only one polyreactive IgG was obtained from each system. Polyreactive anti-polysaccharide IgA responses predominate during hybridoma production and were found for the first time. The selection of polysaccharides as antigens for mucosal immunization could be a strategy to induce a polyreactive response.","PeriodicalId":231101,"journal":{"name":"West Indian Journal of Immunology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129609777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}